RxDoctor Payments Data

Blayne McCaffrey, DPM

Foot & Ankle Surgery · Norfolk, NENPI 1881887263

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.6%), other and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Acera Surgical, Inc. at 34.8% of the total. Reporting peaked in 2022 at $821 and has fallen 78.7% since, to $175 in 2023. That places this record below the midpoint for foot & ankle surgery clinicians in NE, where the typical reported total is $5,810.

$1,738in general payments, 2019–2025

Across 22 payments — averaging $79.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acera Surgical, Inc.$605
  • Orthofix Medical, Inc.$330
  • Musculoskeletal Transplant Foundation Inc.$305
  • Sanara Medtech Inc.$153
  • Medline Industries LP$128
  • Integra Lifesciences Corporation$109
  • plus $107 from 5 others

What the payments were for

  • Travel & lodging$976%
  • Food & beverage$1,03760%
  • Other$60535%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,738 in reported general payments places this provider in the 20th percentile of 43 foot & ankle surgery providers in Nebraska.

See all foot & ankle surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$76,569
Medicare patients
218
Services billed
1,198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin148$3,828
Gabapentin98$3,032
Terbinafine Hcl59$1,176
Diclofenac Sodium37$301
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$253
Amitriptyline Hcl32$218
Doxycycline Hyclate11$118

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →